Clinical pharmacology of aminoglycosides. Part 2.
D000617:Aminoglycosides / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy / Q000662:veterinary*; D002371:Cat Diseases / Q000188:drug therapy; D002415:Cats; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy; D004283:Dog Diseases / Q000188:drug therapy; D004285:Dogs; D005839:Gentamicins / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013552:Swine
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D007612:Kanamycin; D009355:Neomycin; D013307:Streptomycin